The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Emergent Biosolutions Inc (NYSE: EBS) was $9.84 for the day, down -2.77% from the previous closing price of $10.12. In other words, the price has decreased by -$2.77 from its previous closing price. On the day, 1.02 million shares were traded. EBS stock price reached its highest trading level at $10.1 during the session, while it also had its lowest trading level at $9.58.
Ratios:
Our analysis of EBS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.41 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.86. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $16.
On March 07, 2024, The Benchmark Company Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 12 ’24 when DeGolyer Donald W sold 25,000 shares for $10.91 per share. The transaction valued at 272,750 led to the insider holds 111,100 shares of the business.
White Marvin L sold 14,287 shares of EBS for $171,015 on Nov 11 ’24. The Director now owns 54,092 shares after completing the transaction at $11.97 per share. On Nov 12 ’24, another insider, DeGolyer Donald W, who serves as the Director of the company, bought 25,000 shares for $11.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 533172544 and an Enterprise Value of 1059272384. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.47 while its Price-to-Book (P/B) ratio in mrq is 1.05. Its current Enterprise Value per Revenue stands at 0.941 whereas that against EBITDA is -220.682.
Stock Price History:
Over the past 52 weeks, EBS has reached a high of $15.10, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 8.23%, while the 200-Day Moving Average is calculated to be 46.49%.
Shares Statistics:
EBS traded an average of 1.84M shares per day over the past three months and 1360680 shares per day over the past ten days. A total of 54.10M shares are outstanding, with a floating share count of 52.02M. Insiders hold about 3.99% of the company’s shares, while institutions hold 58.52% stake in the company. Shares short for EBS as of 1731628800 were 6812370 with a Short Ratio of 3.71, compared to 1728950400 on 7791409. Therefore, it implies a Short% of Shares Outstanding of 6812370 and a Short% of Float of 15.28.
